ReNeuron GroupCompany research
Click on headlines below to download research
Continuing to gain clinical data in eye disease
ReNeuron Group | 15/01/2021
After an eventful 2020, ReNeuron released updated 12-month Phase ll data in January on its lead human retinal progenitor cell (hRPC) project. This continues…
Funding to complete Phase IIa and other projects
ReNeuron Group | 08/12/2020
ReNeuron is focused on human retinal progenitor cell therapy (hRPC) for retinitis pigmentosa (RP). Ongoing Phase IIa data show a stable average gain in…